Equal treatment efficacy of direct-acting antivirals in patients with chronic hepatitis C and hepatocellular carcinoma? A prospective cohort study

OBJECTIVE: The treatment outcome of direct-acting antivirals (DAAs) in chronic hepatitis C patients with hepatocellular carcinoma (HCC) is controversial. The current study aimed to address the treatment efficacy and safety of DAAs in patients with curative or active HCC, compared with those of patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Chung-Feng, Yeh, Ming-Lun, Huang, Ching-I, Liang, Po-Cheng, Lin, Yi-Hung, Hsieh, Ming-Yen, Wei, Yu-Ju, Lin, Zu-Yau, Chen, Shinn-Cherng, Huang, Jee-Fu, Dai, Chia-Yen, Chuang, Wan-Long, Yu, Ming-Lung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Gastroenterology and Hepatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501994/
https://www.ncbi.nlm.nih.gov/pubmed/31061041
http://dx.doi.org/10.1136/bmjopen-2018-026703

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501994/
https://www.ncbi.nlm.nih.gov/pubmed/31061041
http://dx.doi.org/10.1136/bmjopen-2018-026703

Ejemplares similares